Sensitivity and specificity of DR-70(TM) lung cancer immunoassay

Analytical Letters

Volumn 32, Issue 7, 1999, Pages 1351-1362

  Wu, Dong Fang ^a   Zhou, Xin ^a   Anderson, Gina ^b   Fuentes, Alicia ^d   Slater, Lewis M ^c   Narinesingh, Dyer ^d   Jimenez, Paul ^b   Gopoesingh, Tim ^d  

^a WUHAN UNIVERSITY   (China)

^b AMDL Inc   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d NONE

Author keywords

Cancer test; Lung cancer; Sensitivity and Specificity

Indexed keywords

ADULT; AGED; ARTICLE; BURN; CANCER DIAGNOSIS; CANCER SCREENING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; IMMUNOASSAY; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; RHEUMATOID ARTHRITIS; SCREENING TEST; SEPSIS;

EID: 0344731369     PISSN: 00032719     EISSN: None     Source Type: Journal    
DOI: 10.1080/00032719908542902     Document Type: Article

References (6)

1. th International Conference on Human Tumor Markers, June 11-14, 1995, Hilton Hotel, New York, "Serum Levels of Circulating Extracellular Matrix Complex (CEMC) in Lung Cancer Patients: Potential Use as Tumor Marker" (1995).
2. D. Wu, X. Zhou, G. Yang, Y. Xie, M. Hu, Z. Wu, G. Yang and M. Lu, J. Immunoassay, 19: 63-72 (1998).
3. th International Hamburg Symposium on Tumor Marker, Hamburg, Germany. Abst. 87 (1997).
4. M.H. Zweig and G. Campbell, Clin. Chem., 39: 561-77 (1993).
5. D. Rastel, CYFRA21-1, a Non-Small Cell Lung Cancer Tumor Marker-Report of the First Multicenter Evaluation. In: Klapdor, R., ed. Current Tumor Diagnosis: Applications Clinical Relevance Research-Trends. Munchen: W.Zuckschwerdt Verlag, 210-214 (1994).
6. P. Kenemans, A.A. Verstraeten, G.J. van Kamp and J. Hilgers, Tumor Markers in Gynecology. In: Klapdor, R., ed. Current Tumor Diagnosis: Applications Clinical Relevance Research-Trends. Munchen: W.Zuckschwerdt Verlag, 125-129 (1994).